Filling the need for trusted information on national health issues…

Trending on kff King v. Burwell Medicaid Expansion Consumer Resources

Kaiser Daily Global Health Policy ReportTreatment and Prevention Strategies Search Results « » The Henry J. Kaiser Family Foundation

Treatment and Prevention Strategies

  • your selections
Clear Search

Filter Results

date

Tags

  • results
The Henry J. Kaiser Family Foundation

CDC Leads Consortium Aimed At Eliminating Malaria From Hispaniola By 2020

CDC Foundation: Consortium Aims to Eliminate Malaria on Hispaniola by 2020 Starting With $29.9 Million Grant to CDC Foundation “The U.S. Centers for Disease Control and Prevention (CDC) is leading a consortium of malaria partners aiming to eliminate indigenous cases of malaria on the island of Hispaniola by 2020. Acceleration…

News Summary Read More
The Henry J. Kaiser Family Foundation

U.S. Commitment On Malaria Helping World Progress Down ‘Pathway Toward Elimination’

Huffington Post: The United States and Malaria: A Long History of Smart Investments That Benefit All Fatoumata Nafo-Traoré, executive director of the Roll Back Malaria Partnership “…The U.S. has been a loyal and effective partner to malaria endemic countries around the world for over a decade, and a principal player…

News Summary Read More
The Henry J. Kaiser Family Foundation

Pharmaceutical Industry To Push For Stricter Compulsory Licensing Of Patented Drugs At U.S. Trade Representative Meeting

Wall Street Journal: Pharma Narrowly Defines When Compulsory Licenses Should be Used “As the U.S. Trade Representative holds a hearing [Tuesday] to discuss how countries protect intellectual property, the pharmaceutical industry hopes to persuade the agency that countries should only be allowed to grant licenses to companies to make low-cost…

News Summary Read More
The Henry J. Kaiser Family Foundation

Nature Magazine Outlines Challenges To Ending Ebola Epidemic

Nature: Six challenges to stamping out Ebola “…Highlighting the precariousness of the current situation [in West Africa], on 20 February, the officials leading the United Nations’ Ebola response efforts warned that the gains of the past few months risked unraveling. Nature outlines six of the biggest challenges to stamping out…

News Summary Read More
The Henry J. Kaiser Family Foundation

Washington Post Examines Long Road To Feasible Single-Use Syringe

Washington Post: Why it took so long for the world to start using ‘smart,’ self-destructing syringes “The World Health Organization called Monday for the worldwide use of needle syringes that self-destruct after a single injection. … The WHO has been hunting for solutions for nearly 25 years. Only recently has…

News Summary Read More
The Henry J. Kaiser Family Foundation

News Outlets Report On Results Of HIV Prevention Trials Presented At Conference On Retroviruses And Opportunistic Infections

Agence France-Presse: Pill taken before, after sex may prevent HIV (2/24). Associated Press: Pills before and after sex can help prevent HIV, study finds (Marchione, 2/24). Bloomberg News: Failure of Anti-HIV Gel Shows Difficulty of Prevention (Bloomfield, 2/24). The Guardian: Daily pill Truvada cuts spread of HIV by 86%, study…

News Summary Read More
The Henry J. Kaiser Family Foundation

Global Community Needs To Develop, Deliver Vaccines, Treatments To Prevent Under-5 Mortality

PLOS “Speaking of Medicine”: What Kills Little Kids? Peter Hotez, co-editor in chief of PLOS Neglected Tropical Diseases and dean of the National School of Tropical Medicine at Baylor College of Medicine, and Jennifer Herricks of the National School of Tropical Medicine discuss recently released global mortality data from the…

News Summary Read More
The Henry J. Kaiser Family Foundation

USAID-Supported HIV Prevention Trial Produces Disappointing Results, But Leads To Learning, Redoubled Efforts

USAID’s “IMPACTblog”: How Progress Works: A Disappointing Microbicides Trial and Why We’re Not Discouraged David Stanton, director of USAID’s Office of HIV/AIDS, discusses “results released from a large USAID-supported trial [which] indicate that an antiretroviral-based vaginal gel may not be effective in reducing the risk of HIV infection in women…

News Summary Read More
The Henry J. Kaiser Family Foundation

‘Science Speaks’ Blog Covers Clinical Research Presented At Conference On Retroviruses And Opportunistic Infections

Center for Global Health Policy’s “Science Speaks”: CROI 2015: Study shows “Near elimination of HIV transmission” in a demonstration of PrEP as a bridge to treatment “Science Speaks is covering the 2015 Conference on Retroviruses and Opportunistic Infections in Seattle, Washington, this week, from February 23-26, with breaking news on…

News Summary Read More
The Henry J. Kaiser Family Foundation

Experimental Ebola Drug Shows Promise In Treating Early Infection, Study Shows

Agence France-Presse: Limited promise in early results from Ebola drug trial “Early results from an Ebola trial using the experimental drug Avigan (favipiravir) showed it was somewhat effective at saving lives if given early in the illness, but not later…” (2/23). Reuters: Ebola drug in Guinea helps some, stirs debate…

News Summary Read More